对与帕金森病相关的GBA变体的结构和动态洞察力
Arif Mahmood1, Abdus Samad2, Shazia Bano3
1Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Journal of biomolecular structure & dynamics
|July 12, 2023
概括
在GBA1基因中的帕金森病风险变异会导致葡萄糖大脑酶 (GCase) 的结构变化. 安布罗克索尔对这些GCase变体的结合增强,这表明对帕金森病的潜在治疗益处.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
背景情况:
- 在GBA1基因编码的葡萄糖大脑酶 (GCase),对细胞平衡至关重要.
- GBA1变异与戈舍病和帕金森病 (PD) 有关.
- 与PD相关的GBA1变异的结构和动态影响仍未得到充分研究.
研究的目的:
- 使用计算方法研究GBA1变异的结构和动态影响.
- 分析Ambroxol与野生类型和GCase.变体的结合机制.
- 评估Ambroxol作为与GBA1变异相关的PD治疗剂的潜力.
主要方法:
- 由于基因组变异导致的GBA1结构变化的计算分析.
- 分子对接模拟以评估药物结合亲缘关系.
- 根平均平方偏差 (RMSD),根平均平方波动 (RMSF) 和MM-GBSA分析.
- 评估键和自由结合能量.
主要成果:
- 与PD相关的GBA1变异与野生类型相比,诱导结构变异和异常动态.
- 突变E326K,N370S和L444P对Ambroxol的结合亲和力更高.
- 安布洛克索尔在N370S和L444P变体中表现出更高的稳定性和更强的结合.
- 在Ambroxol对接时,GCase显示了增强的结合亲和力和催化活性.
结论:
- 与PD相关的GBA1变异改变了GCase结构和动态.
- 阿姆布罗克索尔表现出有利的结合特征与特定的GBA1 PD变体.
- 这些发现支持Ambroxol作为GBA1相关PD的治疗策略的潜力.
相关概念视频
Parkinson's Disease: Overview
604
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
604
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
302
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302


